Eli Lilly to buy Dice Therapeutics in $2.4 billion deal
June 20 (Reuters) - Eli Lilly and Co LLY.N will buy Dice Therapeutics Inc DICE.O in an all-cash deal worth about $2.4 billion, the two companies said on Tuesday. (Reporting by Leroy Leo in Bengaluru' Editing by Sriraj Kalluvila) ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources